Publication | Closed Access

Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways

Drug TargetingLonidamine LiposomesMitochondrial Signaling PathwaysDrug-resistant CancerMitochondrial DynamicMedicinePharmacologyAnti-cancer AgentCancer BiologyCell BiologyTumor MicroenvironmentCancer Research